Reactome | empagliflozin [extracellular region]

Schema > ChemicalDrug > Entries

compartment	[Compartment:984] extracellular region
created	[InstanceEdit:9728224] Jassal, Bijay, 2021-04-20
crossReference	[DatabaseIdentifier:12021259] Mondo:0005300
dbId	9728138
disease	[Disease:5669063] type 2 diabetes mellitus [Disease:9608422] congestive heart failure [Disease:9726466] chronic kidney disease
displayName	empagliflozin [extracellular region]
inDisease	true
literatureReference	[LiteratureReference:9728167] Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
maxDepth	1
memberOf	[DefinedSet:R-ALL-9728134] gliflozins [extracellular region]
modified	[InstanceEdit:9728508] Jassal, Bijay, 2021-04-21
name	empagliflozin BI 10773 Jardiance®
referenceEntity	[ReferenceTherapeutic:iuphar.ligand:4754] empagliflozin [Guide to Pharmacology:4754]
schemaClass	ChemicalDrug
stId	R-ALL-9728138

(hasMember)

Cite Us!